15.11.2022 | Article
Where are your HCPs?
MSLs are facing an issue of having increasingly limited access to HCPs
By Tomi Shobande
14.11.2022 | Article
Product Launch Tracker: HCPs share optimism for approvals in heart failure, obesity…
HCP's shared the news on product approvals for issues like obesity, multiple myeloma, etc.
By Paul Cranston and Tomi Shobande
05.07.2022 | Article
Product Launch Tracker: HCPs discuss approvals including for the prevention of smallpox…
HCPs also held around the approval of treatments for monkeypox
By Paul Cranston and Tomi Shobande
02.07.2022 | Article
Product Launch Tracker: HCPs celebrate 5th agnostic approval in Cancer alongside other…
with notable excitement being found for the FDA’s approval of Novartis’ 5th agnostic...
By Paul Cranston and Tomi Shobande
06.06.2022 | Article
Product Launch Tracker: HCPs excited by approvals for Eli Lilly, Novartis, Sanofi…
Over the last month, HCPs discussed product approvals for the treatment of a variety...
By Paul Cranston and Tomi Shobande
19.05.2022 | Article
Product Launch Tracker: HCPs excited for BMS’ newly approved ‘Camzyos’
Discover which new drug approvals HCPs are talking about
By Paul Cranston and Tomi Shobande
13.05.2022 | Article
4 key considerations for healthcare market research
The healthcare industry witnessed a paradigm shift since the COVID-19 pandemic began...
By Tomi Shobande
12.04.2022 | Article
Product Launch Tracker: HCPs discuss approvals for several cancer treatments and a…
HCPs discuss approvals for several cancer treatments and a fourth dose of COVID-19 vaccines
By Paul Cranston and Tomi Shobande
11.03.2022 | Article
Product Launch Tracker: Approvals for Boehringer Ingelheim, Eli Lilly, and Novo Nordisk…
HCPs discuss approvals for Boehringer Ingelheim, Eli Lilly, and Novo Nordisk
By Paul Cranston and Tomi Shobande
09.02.2022 | Article
Product Launch Tracker: HCPs celebrate new treatments for metastatic melanoma and non-small…
HCPs also shared the news of approvals of treatments for NSCLC
By Paul Cranston and Tomi Shobande
10.01.2022 | Article
Product Launch Tracker: Pre-Christmas approvals drive HCPs conversations
Discover which new drug approvals dominated HCPs conversations pre-Christmas...
By Paul Cranston and Tomi Shobande
01.12.2021 | Article
Product Launch Tracker: HCPs welcome approvals for MSD’s Keytruda and Takeda’s Livtencity
Discover which new drug approvals HCPs are talking about
By Paul Cranston and Tomi Shobande